New heterocyclic compounds spiroderivatives of
allopurinol of biological interest were prepared from
allopurinol via thionation and 1,3-dipolar
cycloaddition and were produced in high to excellent
yields. These compounds were characterized on the basis of spectral and spectroscopic data (1H NMR, 13C, IR, and MS).
The antibacterial activity of the synthesized products was studied
using bacterial strains: Staphylococcus aureus,
Enterococcus faecalis, Escherichia
coli, and Pseudomonas aeruginosa.
Compounds having an ethyl group showed the best activity with MIC
value of 31.25 µg/mL against Staphylococcus
aureus and Streptococcus fasciens.
1. Introduction
Heterocycles are widely distributed in nature and play a key role in the metabolism of all living cells. Among the many heterocyclic compounds containing nitrogen, the pyrazolopyrimidine ring is very interesting and versatile scaffold for the synthesis of potential drugs or molecular tools (Figure 1). Among their many applications, pyrazolo[3,4-d]pyrimidines (Figure 2) were used as inhibitor kinases [1, 2] antiviral agents [3, 4], adenosine antagonists [5–7], glutamate modulators [8], antituberculosis agents [3], and as antibiotics inhibit bacterial growth [9, 10].
Pyrazolopyrimidine containing drugs.
Example of bioactive molecules derived from pyrazolo[3,4-d]pyrimidine and thiadiazole.
In light of the great importance of spirocyclic systems containing one carbon atom common to two rings [11–13], in recent years efforts have been made in developing methodologies for the synthesis of these compounds especially by cycloaddition reactions [14–22].
1,3-Dipolar cycloaddition is a subject of intense research during the last decade due to its great synthetic value. The cycloaddition is a method of synthesis of five membered heterocycles, which are difficult to prepare by other means.
Generally, reactions of 1,3-dipoles with true heterocyclic thiones having the thione form A proceed via 1,3-dipolar cycloaddition to the C=S double bond to form the spirocycloadducts, namely, spirothiadiazoles. The reaction of heterocyclic thiones A with nitrilimines, generated in situ by base-catalyzed dehydrohalogenation of hydrazonoyl halides, has been described for synthesis of various derivatives of spiro[heterocycle-n,2′-3H-1,3,4-thiadiazole] B (Figure 3).
Synthesis of spiroheterocycles.
In continuation of our work on the synthesis of the excess of allopurinol [23–28], compounds 2 and 2a-b have been synthesized by using reported methods [29–31]. Herein we report simple efficient synthesis of spiro thiadiazoline-(pyrazolo[3,4-d]pyrimidine) derivatives 4a-b by 1,3-dipolar cycloaddition of diphenyl hydrazonoyl chloride 3 with an equimolecular amount of pyrazolo[3,4-d]pyrimidin-4(5H)-thione derivatives 2a-b. All the synthesized compounds were evaluated for their antibacterial activity.
2. Materials and Methods
Generally the melting points were taken on an electrothermal capillary melting point apparatus. Infrared spectra (ν-cm−1) were recorded on a Perkin Elmer 577, using KBr disks. 1H NMR and 13C NMR spectra were recorded on Bruker Avance 300 NMR Spectrometer in DMSO-d6. Spectra were internally referenced to TMS. Peaks are reported in ppm downfield of TMS. Mass spectra are recorded in a SYNAPT G2 HDMS (Waters) Spectrometer in electrospray ionization (ESI).
2.1. Thionation
3.67 mmol of pyrazolo[3,4-d]pyridine is refluxed in pyridine with 3.67 mmol of phosphorus pentasulfide for 4 hours. Then the solvent is evaporated under reduced pressure, and the precipitate formed is washed with hot water to remove residual dimerized P2S5 until there is colorless filtrate.
To a solution of 1,5-diethyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thione (10 mmol) and diphenylnitrilimine (1.3 × 10 mmol) in THF (30 mL) triethylamine (2 mL) was added. The mixture was refluxed for 24 hours. The precipitate was collected by filtration and was separated by silica gel chromatography (hexane/ethyl acetate: 8/2).
We first prepared 1,5-diethyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thiones 2a-b from 1a-b by refluxing phosphorus pentasulfide in pyridine. The identification of the product was determined by 1H NMR, 13C NMR, IR, and mass spectra.
IR-spectra of compounds 2a-d did not contain C=O-group signals, the signal of C=S group (1500cm−1) was present. The spectra of 13C NMR corroborated the results of IR. In addition, its mass spectrum shows a molecular ion peak at m/z 152 (M+) corresponding to the molecular formula C5H4N4S compound 2, molecular ion at m/z 208.07 (M+) corresponding to the molecular formula C9H12N4S compound 2a and molecular ion at m /z 332.10 (M+) corresponding to the molecular formula C19H16N4S compound 2b (Scheme 1, Figure 4) [23].
Thionation of 1,5-dialkyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one 1a-b.
ORTEP presentation of compound 2b.
We investigated the reaction of 1,3-dipolar cycloaddition of diphenyl hydrazonoyl chloride 3 with equimolecular amount of 1,5-diethyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-thione 2a in dry tetrahydrofuran in presence of triethylamine (Scheme 2); one cycloadduct was obtained as a result of 1,3-dipolar cycloaddition of diphenyl nitrile imine ylide generated in situ from diphenyl hydrazonoyl chloride and triethylamine, on the dipolarophilic group C=S.
1,3-Dipolar cycloaddition of 1,5-diethyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thione 2a and DPNI 3.
The structure of these compounds was confirmed on the basis of their spectroscopic characteristics. The 1H NMR spectra of 4a (in DMSO-d6) showed an aromatic multiplet in the region of 6.83 to 7.67 ppm corresponding to the aromatic protons. Two downfield singlets were observed in the region of 7691–7968 ppm representing the protons for CH in pyrimidine ring and CH in pyrazole ring because of the high incidence of the aromatic ring system deshielding protons CH pyrimidine CH pyrazole. 1H NMR spectra of 4a also showed the CH2 and CH3 signals as triplets and multiplets and between 1.12 and 1.27 ppm and between 3.37 and 4.11 ppm, respectively. 13C NMR spectra of 4a exhibit in signal spirocarbon to 99.70 ppm, aromatic carbons 100.79 to 129.38 ppm, and the imine carbon to 142.2 and 139.93 ppm (HC=N). The mass spectrum shows a peak at m/z 403.16 corresponding to [M + H].
In order to examine the N-substitution effect of alkyl group on the 1,3-dipolar cycloaddition, 1,5-dibenzyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-thione 2a was chosen to be employed to react with DPNI. So in this case it was found that C=S group underwent the 1,3-dipolar cycloaddition reaction and formed of novel spiro[thiadiazoline-(pyrazolo[3,4-d]pyrimidine)] (Scheme 3).
1,3-Dipolar cycloaddition of 1,5-dibenzyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thione 2b and DPNI.
The structure of compound 4b was established by IR, 1H NMR, 13C NMR, and mass spectrum. Its IR spectrum showed a characteristic absorption band at 1647 cm−1 for the >C=N- indicating the spirocarbon formation. Its 1H NMR spectrum exhibited peaks at 7.25–7.32 ppm (20H) indicating the presence of aromatic protons. The two singlets at 3.65 ppm and 4.28 ppm relating to two protons of the two CH2 groups were also observed. 13C NMR spectra of 4b exhibited, in particular, a spiro carbon signal at 77.2 ppm. The mass spectrum shows a peak at m/z 527.39 corresponding to [M + H].
3.1. In Vitro Antibacterial Activity
We studied spiropyrazolo[3,4-d]pyrimidines newly synthesized for their antibacterial activity against Escherichia coli (ATTC-25922), Staphylococcus aureus (ATCC-25923), Pseudomonas aeruginosa (ATCC 27853), and Enterococcus faecalis (ATCC-29212) strains of bacteria by the diffusion method disk [32]. The MIC values of the compound against bacteria are presented in Table 1.
Antibacterial activity of the compounds: MIC in μg/mL.
Product
MIC in μg/μL
S. aureus
E. faecalis
E. coli
P. aeruginosa
1
250
125
250
250
1a
250
250
250
—
1b
125
62.5
62.5
250
2
250
125
125
250
2a
250
125
250
250
2b
250
250
250
250
4a
125
62.5
125
250
4b
31.25
31.25
125
125
Chlor
1.875
3.75
15
7.5
Amp
2.5
1.25
5
5
MIC: minimum inhibitory concentration.
We synthesized new spirocompounds with a high yield by cycloaddition reaction. They have showed moderate antibacterial activity against selected bacteria. All these compounds showed at an average concentration low antibacterial activity against the bacteria, except that compounds 1a and 4a showed higher activity, even at higher concentrations. Compound 4b showed higher activity against S. aureus and E. faecalis compared to bacteria E. coli and P. aeruginosa.
4. Conclusion
In conclusion, a new class of heterocyclic spiro[thiadiazoline pyrazolopyrimidine] compounds was synthesized and their structure was determined and also tested for their antibacterial activity in vitro. This study is expected to take the tests of anti-inflammatory drugs, antifungal, and anticancer activity because the literature gives some very interesting results on these topics.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Acknowledgment
The authors thank Pharmaceutical Laboratories PHARMA 5 for supporting this study.
DinérP.AlaoJ. P.SöderlundJ.SunnerhagenP.GrøtliM.Preparation of 3-substituted-1-isopropyl-1 H-pyrazolo[3,4-d]pyrimidin-4- amines as RET kinase inhibitors201255104872487610.1021/jm30039442-s2.0-84861488377YangL. L.LiG. B.YanH. X.SunQ. Z.MaS.JiP.WangZ. R.FengS.ZouJ.YangS. Y.Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization201256303810.1016/j.ejmech.2012.08.007ChernJ.-H.ShiaK.-S.HsuT.-A.TaiC.-L.LeeC.-C.LeeY.-C.ChangC.-S.TsengS.-N.ShihS.-R.Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors200414102519252510.1016/j.bmcl.2004.02.0922-s2.0-1942438497BektemirovT. A.ChekunovaE. V.KorbukhI. A.Bulychev YuN.YakuninaN. G.PreobrazhenskayaM. N.Antiviral activity of substituted 6-methylmercaptopyrazolo(3,4-d)pyrimidines and their ribosides19812553263292-s2.0-0019793947TalianiS.La MottaC.MugnainiL.SimoriniF.SalernoS.MariniA. M.Da SettimoF.CosconatiS.CosimelliB.GrecoG.LimongelliV.MarinelliL.NovellinoE.CiampiO.DanieleS.TrincavelliM. L.MartiniC.Novel N2-Substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-Mediated human glioblastoma cell proliferation201053103954396310.1021/jm901785w2-s2.0-77952711968BrielD.AurichR.EgerlandU.UnverferthK.Synthese substituierter 6-Phenylpyrazolo[3,4-d]pyrimidine mit potenziell Adenosin-A2A-antagonistischer Wirkung20056010732735PoulsenS.-A.QuinnR. J.Synthesis and structure-activity relationship of pyrazolo[3,4- d]pyrimidines: potent and selective adenosine A1 receptor antagonists199639214156416110.1021/jm960052s2-s2.0-0029796714NiswenderC. M.LeboisE. P.LuoQ.KimK.MuchalskiH.YinH.ConnP. J.TrivediA. R.DholariyaB. H.VakhariyaC. P.DodiyaD. K.RamH. K.KatariaV. B.SiddiquiA. B.ShahV. H.Synthesis and anti-tubercular evaluation of some novel pyrazolo[3,4-d]pyrimidine derivatives2012211887189110.1007/s00044-011-9712-3HollaB. S.MahalingaM.KarthikeyanM. S.AkberaliP. M.ShettyN. S.Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents20061462040204710.1016/j.bmc.2005.10.0532-s2.0-32044468685BhambiD.SalviV. K.JatJ. L.OjhaS.TalesaraG. L.Synthesis and antimicrobial activity of some new indole containing isoxazolines and phthalimidoxy derivatives of thiazolidinone and thiohydantoin200728215516310.1080/174159906011549462-s2.0-33947713460FattyR. A. M.GaafarA. M.YoussefA. M. S.A simple and efficient synthesis of new substituted benzothienopyridazine spiro- derivatives of pyrazolone, pyrimidinone and diazepinone20113222228GajeraN. N.PatelM. C.Synthesis, characterization and biological screening of new spirochromanones20124733773382RaneB. S.DeshmukhS. V.GhagareM. G.RoteR. V.JachakM. N.Synthesis of spiro-pyrimido [4,5-b]quinoline and study of their antimicrobial activities201247356235672-s2.0-84867599548YerrabellyJ. R.ChakravarthulaV.YerrabellyH.ChitneniP. R.BatchuV. R.NanuboluJ. B.KrishnanR. K.Unusual tandem ring closing metathesis—Claisen rearrangement enroute to spiro annulation of O-allyl biscoumarins201556172180218210.1016/j.tetlet.2015.02.106DeK.BhaumikA.BanerjeeB.MukhopadhyayC.An expeditious and efficient synthesis of spiro-pyrazolo[3,4-b]pyridines catalysed by recyclable mesoporous aluminosilicate nanoparticles in aqueous-ethanol201556131614161810.1016/j.tetlet.2015.01.163AbourichaS.RakibE. M.BenchatN.AlaouiM.AllouchiH.El BaliB.Facile synthesis of new spirothiadiazolopyridazines by 1,3-dipolar cycloaddition200535162213222110.1080/003979105001826972-s2.0-23844496091BudarinaE. V.LabeishN. N.Bel'SkiiV. K.GalishevV. A.Hetrocyclic thiones and their analogs in reactions of 1,3-dipolar addition: v. Reactions of 2,3,3-triphenyl-1-thioxophthalimidine with nitrile imines200541575876110.1007/s11178-005-0240-92-s2.0-22444434117EssassiE. M.AhoyaC.BouhfidR.DaoudaB.HançaliA.ZouihriH.ZerzoufA.El AouadR.Synthesis and antibacterial activity of new spiro[thiadiazoline-quinoxaline] derivatives20112011221722610.3998/ark.5550190.0012.217Al MamariK.EnnajihH.ZouihriH.BouhfidR.NgS. W.EssassiE. M.Synthesis of novel dispiro-oxindoles via 1,3-dipolar cycloaddition reactions of azomethine ylides201253182328233110.1016/j.tetlet.2012.02.0972-s2.0-84859265236ZhangY.-X.DingL.LiuX.-Y.JiangZ.-Q.ChenH.JiS.-J.LiaoL.-S.Spiro-fused N-phenylcarbazole-based host materials for blue phosphorescent organic light-emitting diodes20152011211810.1016/j.orgel.2015.02.014DasP.OmolloA. O.SitoleL. J.McClendonE.ValenteE. J.RaucherD.WalkerL. R.HammeA. T.Synthesis and investigation of novel spiro-isoxazolines as anti-cancer agents201556141794179710.1016/j.tetlet.2015.02.059Naga Siva RaoJ.RaghunathanR.A facile synthesis of glyco 3-nitrochromane hybrid pyrrolidinyl spiro heterocycles via [3+2] cycloaddition of azomethine ylides201556172276227910.1016/j.tetlet.2015.03.069El FalM.RamliY.EssassiE. M.SaadiM.El AmmariL.The crystal structure of 1,5-dibenzyl-1H-pyrazolo[3,4-d]pyrimidine-4(5H)-thione201571o95o9610.1107/s205698901402828xEl FalM.RamliY.EssassiE. M.SaadiM.El AmmariL.Crystal structure of 4-allylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine201470o103810.1107/s1600536814018042El FalM.RamliY.EssassiE. M.SaadiM.El AmmariL.Crystal structure of 1-ethylpyrazolo[3,4-d]pyrimidine-4(5H)-thione2014709o1005o100610.1107/s160053681401825xAlsubariA.RamliY.EssassiE. M.ZouihriH.5-(Pyridin-4-ylmeth-yl)-1Hpyrazolo-[3,4-d]pyrimidin-4(5H)-one201167part 8o192610.1107/s16005368110250252-s2.0-80051538351El FalM.RamliY.EssassiE. M.SaadiM.El AmmariL.4-benzylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine20136911o165010.1107/s160053681302789x2-s2.0-84887218663El FalM.RamliY.EssassiE. M.SaadiM.El AmmariL.Crystal structure of 1-methyl-4-methylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine2014E70o128110.1107/S1600536814025239El OualiI.HammoutiB.AounitiA.RamliY.AzougaghM.EssassiE. M.BouachrineM.Thermodynamic characterisation of steel corrosion in HCl in the presence of 2-phenylthieno (3, 2-b) quinoxaline201011182-s2.0-78049297719BadrM. Z. A.El-NaggarG. M.El-SheriefH. A. H.Abdel-RahmanA. E. S.AlyM. F.Reaction of quinoxaline derivatives with nucleophilic reagents198356132633010.1246/bcsj.56.326MoustafaO. S.Synthesis and some reactions of Quinoxalinecarboazides200047351357SirotJ.19902ndParis, FranceFlammarion